GlassScriptPhysician profile
Comana Cioroiu
NPI 1952543647
$1,250.53
in general payments reported to CMS, 2019-2025
15 companies · $192 in 2025
The $192 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $832 · 2020: $49.92 · 2021: $135 · 2022: $20.84 · 2024: $20.14 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $212.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $508.47 | 2019-2021 | |
| Akcea Therapeutics, INC. | $223.19 | 2019 | |
| Eisai INC. | $103.47 | 2025 | |
| Abbvie INC. | $84.78 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $75.95 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $58.45 | 2021 | |
| Csl Behring | $30.22 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $24.96 | 2021 | |
| Pfizer INC. | $24.34 | 2025 | |
| Genzyme Corporation | $22.41 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.84 | 2022 | |
| Lundbeck LLC | $20.09 | 2019 | |
| Catalyst Pharmaceuticals, INC. | $18.69 | 2021 | |
| Alnylam Pharmaceuticals INC. | $18.05 | 2019 | |
| Strongbridge US INC. | $16.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Comana Cioroiu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.